(Q33992344)

30 July 2017

1 reference

title

One hundred years of poliovirus pathogenesis (English)

1 reference

30 July 2017

0 references

poliovirus

1 reference

Vincent R Racaniello

1

1 reference

PubMed ID

16364730

30 July 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

30 July 2017

1 reference

30 July 2017

344

1 reference

30 July 2017

1

1 reference

30 July 2017

9-16

1 reference

Three-dimensional structure of poliovirus receptor bound to poliovirus

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Picornavirus RNA translation: roles for cellular proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Emerging Concept of Poliomyelitis Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

The clathrin endocytic pathway in viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

The neuropathology observed in wild-type mice inoculated with human poliovirus mirrors human paralytic poliomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Attenuation stem-loop lesions in the 5' noncoding region of poliovirus RNA: neuronal cell-specific translation defects

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

7 January 2021

Interaction of the poliovirus receptor with poliovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Poliovirus cell entry: common structural themes in viral cell entry pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Receptor affinities as major determinants of enterovirus tissue tropisms in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

The mammalian cell-virus relationship. IV. Infection of naturally insusceptible cells with enterovirus ribonucleic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Host range of poliovirus is restricted to simians because of a rapid sequence change of the poliovirus receptor gene during evolution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Pathogenesis of human poliovirus infection in mice. I. Clinical and pathological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Pathogenesis of human poliovirus infection in mice. II. Age-dependency of paralysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Poliovirus tropism and attenuation are determined after internal ribosome entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Transgenic mice susceptible to poliovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene--influence of the transgene expression on pathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Expression of poliovirus receptor in human spinal cord and muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Adaptation of type I poliomyelitis virus to mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Shedding of sabin poliovirus Type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Recruitment of nectin-3 to cell-cell junctions through trans-heterophilic interaction with CD155, a vitronectin and poliovirus receptor that localizes to alpha(v)beta3 integrin-containing membrane microdomains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Interaction of the poliovirus receptor CD155 with the dynein light chain Tctex-1 and its implication for poliovirus pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Proteolytic Cleavage of the p65-RelA Subunit of NF-κB during Poliovirus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Vaccine-Associated Paralytic Poliomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Retrograde transport of intact poliovirus through the axon via the fast transport system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Poliovirus spreads from muscle to the central nervous system by neural pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Pathogenesis of poliomyelitis; reappraisal in the light of new data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

THE NATURAL HISTORY OF HUMAN POLIOMYELITIS : I. DISTRIBUTION OF VIRUS IN NERVOUS AND NON-NERVOUS TISSUES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Herpes simplex virus: receptors and ligands for cell entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Primary sites of virus multiplication following intramuscular inoculation of poliomyelitis virus in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Distinct cellular receptor interactions in poliovirus and rhinoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Tissue-Specific Replicating Capacity of a Chimeric Poliovirus That Carries the Internal Ribosome Entry Site of Hepatitis C Virus in a New Mouse Model Transgenic for the Human Poliovirus Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

Attenuating mutations in the poliovirus 5' untranslated region alter its interaction with polypyrimidine tract-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

7 January 2021

Mammalian cell-virus relationship. III. Poliovirus production by non-primate cells exposed to poliovirus ribonucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

7 January 2021

Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

7 January 2021

Identification of two determinants that attenuate vaccine-related type 2 poliovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.09.015

7 January 2021

10.1016/J.VIROL.2005.09.015

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

16364730